{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-023768","form_type":"8-K","ticker":"CLDX","cik":"0000744218","company_name":"Celldex Therapeutics, Inc.","filed_at":"2023-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.963146+00:00","generated_at":"2026-06-19T07:30:00.722362+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Celldex appoints Rita Jain, M.D. to Board of Directors","bullets":["Rita Jain, M.D. appointed to Celldex Board effective February 16, 2023.","Dr. Jain receives initial option grant for 17,100 shares vesting over three years.","She previously served as CMO of ChemoCentryx and Immunovant, and SVP/CMO at Akebia.","Dr. Jain currently serves on boards of Provention Bio and AM Pharma supervisory board.","Appointment fills board vacancy; no family relationships or material transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-023768","json":"https://secwatch.observer/filing/0001104659-23-023768.json","markdown":"https://secwatch.observer/filing/0001104659-23-023768.md","text":"https://secwatch.observer/filing/0001104659-23-023768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744218/000110465923023768/0001104659-23-023768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744218/000110465923023768/tm237425d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T07:30:00.722362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"925c93782d","claim":"Rita Jain, M.D. was appointed as member of the Board of Directors at Celldex Therapeutics, Inc..","evidence_excerpt":"Rita Jain, M.D. was appointed as a member of our Board of Directors (the “ Board ”) on February 16, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/744218/000110465923023768/0001104659-23-023768-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}